Session Title: Vascular Diseases & Anterior/posterior segment surgery
Session Date/Time: Sunday 29/09/2013 | 11:00-13:00
Paper Time: 11:24
Venue: Hall 3 (Level 0)
First Author: A.Souka EGYPT
Co Author(s): S. Soliman
To document changes in intraocular pressure (IOP) and grade if iris neovascularization (NVI) in patients with neovascular glaucoma (NVG) after Intracameral bevacizumab injection as an anti-vascular endothelial growth factor (VEGF); the cause of new vessel formation.
Faculty of Medicine, Alexandria Main University Hospital (iris photography and follow up) i-Care eye Hospital (intracameral injection)
A retrospective review of eyes with NVG that were injected by single intracameral bevacizumab injection (2.5 mg/0.1ml), IOP measurements and NVI grading with Laatikainen Grading system were done and compared both preoperatively and post operatively.
12 eyes of 10 patients with NVG were injected. Eyes with pre-injection IOP ≤ 21 mmHg show stability throughout follow up period (3 months) while eyes with IOP > 21 mmHg showed a significant (p<0.0001) decrease in IOP. Regression of NVI was inversely proportional to pre-injection grade
Intracameral bevacizumab can be used to control high IOP in NVG.